Sean Tonzi
About Sean Tonzi
Sean Tonzi is the Associate Director of CMC Strategy at Bristol-Myers Squibb in Syracuse, NY, with over 40 years of experience in biology and chemistry.
Current Role at Bristol-Myers Squibb
Sean Tonzi currently serves as the Associate Director of CMC Strategy at Bristol-Myers Squibb. He has been in this role since November 2017, based in Syracuse, New York. In this position, he is involved in developing and implementing strategies related to Chemistry, Manufacturing, and Controls (CMC) for biologic products. His expertise is fundamental in ensuring the quality and regulatory compliance of Bristol-Myers Squibb's pharmaceutical products.
Previous Roles within Bristol-Myers Squibb
Sean Tonzi has held several significant leadership positions within Bristol-Myers Squibb. These roles include Manager - Process Analytical Sciences and Group Leader - Biologics Analytical Development & Testing. In these capacities, he has overseen the analytical development and testing of biologics and has played a vital role in process analytics. His extensive experience in these fields supports the company's goals of innovation and excellence in biopharmaceutical development.
Educational Background
Sean Tonzi attended LeMoyne College, where he studied Biology and Chemistry. He earned his Bachelor of Science (B.S.) degree over a four-year period from 1978 to 1982. This educational foundation provided him with the necessary knowledge and skills to pursue a career in the fields of biology and analytical chemistry, leading to a substantial career spanning over four decades.
Expertise in Biology and Chemistry
With over 40 years of experience, Sean Tonzi brings a wealth of knowledge and expertise in both biology and chemistry. His career has been characterized by a deep understanding of the analytical and developmental processes within the biopharmaceutical industry. His contributions have been instrumental in advancing analytical methods and ensuring the quality of biologic products at Bristol-Myers Squibb.